Table 2.
Univariate analysis | Multivariable analysis | |||||
---|---|---|---|---|---|---|
HR | 95% CI | P value | HR | 95% CI | P value | |
Gender | 0.807 | 0.506 - 1.288 | 0.369 | 0.873 | 0.543-1.402 | 0.573 |
(Male vs. Female) | ||||||
Age | 1.503 | 0.989-2.283 | 0.056 | 1.26 | 0.811-1.957 | 0.303 |
(< 65 vs. ≥ 65) | ||||||
KPS | 1 | 0.622-1.608 | 0.999 | 1.706 | 0.666-1.736 | 0.766 |
(≥ 80 vs. < 80) | ||||||
Clinical stage | 2.96 | 1.49-5.88 | 0.002 | 2.889 | 1.452-5.749 | 0.003 |
(I-II vs. III) | ||||||
Timing of RT | 1.381 | 0.770-2.478 | 0.278 | 1.315 | 0.722-2.396 | 0.37 |
(Early vs. Late) | ||||||
PCI | 0.611 | 0.408-0.915 | 0.017 | 0.684 | 0.445-1.049 | 0.082 |
(No vs. Yes) |
HR, hazard ratio; CI, confidence interval; RT, radiotherapy; CRT, chemoradiotherapy; KPS, Karnofsky Performance Score.